Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From … – CNNMoney

Relmada Therapeutics Reinforces Balance Sheet With $15.2 Million From
CNNMoney
… Inc., (OTCQB: RLMD), a clinical-stage company developing novel therapies for the treatment of chronic pain, announced today the issuance of approximately 10.1 million of its shares of common stock pursuant to the exercise of A-Warrants originally

…read more

Scroll to Top